← Browse by Condition
Medical Condition
arb
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT04367883
Recruiting
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Enrollment
3,000 pts
Location
Spain
Sponsor
Consorci Sanitari de Terrassa
NCT07185256 Phase 1, Phase 2
Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Enrollment
10 pts
Location
United States
Sponsor
Opus Genetics, Inc